The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives
Status:
Withdrawn
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether vilazodone is more effective than
citalopram for the treatment of anxious depression. We will use neuroimaging to see whether
there are changes in the brains of patients receiving the drug vilazodone that are different
from those of citalopram. These changes may show that vilazodone affects the brain
differently than most other kinds of standard antidepressant medications.